The new treatment is tolerable for the human body.
Category: biotech/medical – Page 1920
Let’s face it, getting older sucks, and not because of all the extra candles on the birthday cake. Getting cake and presents every year is great, but the loss of health and independence isn’t a particularly good birthday present. (Wow, what’d I get this year? Just what I didn’t want: sarcopenia and hearing loss!)
Given the downsides of aging, it really is surprising how little people talk about it beyond the odd grumble or even as a joke. Normally, it’s to complain about the aches and pains that gradually appear as the years roll by, as we find it harder to walk up the stairs and “bright-eyed and bushy-tailed” turns into “cloudy-eyed and with an aching back”.
That’s not even the serious side of aging, which involves the gradual loss of independence and the age-related diseases that first rob us of our quality of life before they get around to killing us. The serious part is the horror of Alzheimer’s and the loss of self that it brings, the heart disease that cripples us, the frailty that steals our independence, and the lurking threat of cancer that rises dramatically as we age.
Coronavirus-cure-indian-scientists-team-is-very-close-to-developing-vaccine-for-coronavirus.
In a major breakthrough that can lead to a quick Coronavirus vaccine, a team of scientists led by an overseas citizen of India, Professor SS Vasan of CSIRO (Commonwealth Scientific and Industrial Research Organization) Dangerous Pathogens Team has successfully mass produced the novel Coronavirus strain outside China in sufficiently large number to begin clinical trial of medicine.
According to reports, last week Australia’s Doherty Institute had managed to isolate the Coronavirus sample from an infected human in Australia, but what Prof SS Vasan and his team has done at CSIRO is significantly better for getting to a Coronavirus vaccine quickly.
It shows how hard tumours will be to crack.
#survival #coronavirus
In light of recent events its a good opportunity to go over the basics of pandemic preparedness.
*Correction* I need to make a correction to information provided within this video. The case-fatality rate of the Spanish influenza is often quoted by virologists as 2.5 % when in reality the math on this doesn’t add up as the population of the planet at the time doesn’t align with this statistic. This stat is misinterpreted to mean the overall case-fatality rate was (greater than) 2.5%. It is presumed a safer mortality estimate was between 7.5%-15% at the pandemics peak wave. The correct statistic is the 2.5%-5% of the WORLDS population perished as a result of this. It should be noted that there were several waves to this pandemic hence the 2.5 (greater than) statistic. The first wave was relatively tame, the second wave was devastating, the third wave was less severe. https://www.cdc.gov/flu/pandemic-resources/1918-commemoration/three-waves.htm
Similar videos
Hazsuit
Biohazard bags
Front Microbiol. 2018 Sep 27;9:2338. doi: 10.3389/fmicb.2018.02338. eCollection 2018.
Influenza A virus causes periodic outbreaks and seriously threatens human health. The drug-resistant mutants have shown an epidemic trend because of the abuse of chemical drugs. Aloe polysaccharides (APS) extracted from Aloe vera leaves have evident effects on the therapy of virus infection. However, the activity of APS in anti-influenza virus has yet to be investigated. Here, we refined polysaccharides from A. vera leaf. In vitro test revealed that APS could inhibit the replication of a H1N1 subtype influenza virus, and the most obvious inhibitory effect was observed in the viral adsorption period. Transmission electron microscopy indicated that APS directly interacted with influenza virus particles. Experiments on PR8 (H1N1) virus infection in mice demonstrated that APS considerably ameliorated the clinical symptoms and the lung damage of the infected mice, and significantly reduced the virus loads and mortality.
Successfully coronavirus treatment on a critically ill 71-year woman.
Thai doctors have declared the use of anti-flu and AIDS drugs a success in reducing symptoms of coronavirus patients after using them on a Chinese woman.
Two doctors from Rajavithi Hospital in Bangkok — Dr Kriangsak Atipornwanich, an expert physician, and Assoc Prof Dr Subsai Kongsangdao, a specialist — said at a briefing in Bangkok that improvements were seen in the 71-year-old woman 48 hours after administering the two groups of medications.
The woman was admitted first to Hua Hin Hospital and then transferred to Rajavithi Hospital on Jan 29.
Using genetically-edited cells to supercharge the immune system caused no adverse effects in cancer patients. It’s too soon to tell if it can be a cure.
Scientists from the UNC School of Medicine, Columbia University, and Rockefeller University have revealed the inner workings of one of the most fundamental and important molecular machines in cells.
The researchers, in a study published in Science, used biochemical experiments and cryo–electron microscopy (cryo-EM) to determine the atomic structure of a complex assembly of molecules known as the histone mRNA three-prime (3’) end-processing machine. This machine plays a fundamental role in proper activity and duplication of the cell genome and when defective, it may lead to human diseases, including cancers.
Histone proteins are found in all plants and animals, and they form a “beads-on-a-string” arrangement where the DNA in chromosomes is wrapped around the beads of histones. Histones ensure the efficient packaging of DNA and help regulate which genes are turned “on” and which are kept “off,” processes needed for all cells to function properly.
China has applied to patent a drug candidate being developed by US biotechnology firm Gilead Sciences in its search for a cure for coronavirus infection. It could raise questions on intellectual property and marketing rights.